| Medical and Health Sciences | 2021-2025 | 483 | JP 3 | 99.90 |
| Biological Sciences | 2021-2025 | 783 | JP 10 | 99.16 |
| Clinical Neurology | Lifetime | 39 | JP 1 | 99.87 |
| Epidemiology | Lifetime | 821 | JP 21 | 98.90 |
| Neuroscience of Neurology | Lifetime | 229 | JP 8 | 98.18 |
| Cellular and Molecular Neuroscience | Lifetime | 460 | JP 8 | 98.27 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 857 | JP 9 | 96.82 |
| Clinical Biochemistry | Lifetime | 788 | JP 22 | 79.85 |
| Hepatology | Lifetime | 903 | JP 59 | 77.98 |
| Clinical Neurology | 2021-2025 | 6 | JP 1 | 99.75 |
| Neuroscience of Neurology | 2021-2025 | 79 | JP 1 | 95.83 |
| Medical Physiology | 2021-2025 | 280 | JP 6 | 96.21 |
| Cellular and Molecular Neuroscience | 2021-2025 | 93 | JP 3 | 92.59 |
| Epidemiology | 2021-2025 | 710 | JP 19 | 93.13 |
| Pathology and Forensic Medicine | 2021-2025 | 335 | JP 8 | 88.36 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 824 | JP 20 | 79.89 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 38 | JP 1 | 99.83 |
| Autophagy in Disease and Therapy | Lifetime | 67 | JP 7 | 99.50 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 97 | JP 1 | 99.47 |
| Nuclear Receptors and Signaling | Lifetime | 30 | JP 1 | 99.51 |
| RNA regulation and disease | Lifetime | 64 | JP 4 | 98.97 |
| Neurological diseases and metabolism | Lifetime | 41 | JP 1 | 99.42 |
| Genetic Neurodegenerative Diseases | Lifetime | 124 | JP 5 | 99.07 |
| Ubiquitin and proteasome pathways | Lifetime | 287 | JP 13 | 98.60 |
| Mitochondrial Function and Pathology | Lifetime | 558 | JP 29 | 98.31 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 294 | JP 3 | 98.23 |
| Ginkgo biloba and Cashew Applications | Lifetime | 43 | JP 3 | 97.71 |
| Lysosomal Storage Disorders Research | Lifetime | 169 | JP 8 | 97.83 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 34 | JP 1 | 98.01 |
| Neurological and metabolic disorders | Lifetime | 162 | JP 11 | 96.59 |
| Restless Legs Syndrome Research | Lifetime | 80 | JP 3 | 97.39 |
| Cellular transport and secretion | Lifetime | 575 | JP 34 | 97.13 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 772 | JP 22 | 96.61 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 796 | JP 18 | 96.74 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 448 | JP 36 | 96.44 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 545 | JP 49 | 94.56 |
| Aortic Thrombus and Embolism | Lifetime | 107 | JP 11 | 91.26 |
| Peripheral Neuropathies and Disorders | Lifetime | 947 | JP 54 | 93.81 |
| Cerebrovascular and genetic disorders | Lifetime | 370 | JP 35 | 87.67 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 870 | JP 39 | 88.53 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 872 | JP 110 | 82.13 |
| Hydrogen's biological and therapeutic effects | Lifetime | 875 | JP 134 | 71.34 |
| Hallucinations in medical conditions | Lifetime | 723 | JP 39 | 37.77 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 6 | JP 1 | 99.70 |
| RNA regulation and disease | 2021-2025 | 4 | JP 1 | 98.66 |
| Neurological diseases and metabolism | 2021-2025 | 5 | JP 1 | 98.54 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 28 | JP 1 | 99.18 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 52 | JP 1 | 97.12 |
| Autophagy in Disease and Therapy | 2021-2025 | 83 | JP 6 | 96.17 |
| Nuclear Receptors and Signaling | 2021-2025 | 15 | JP 2 | 94.47 |
| Lysosomal Storage Disorders Research | 2021-2025 | 96 | JP 2 | 94.56 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 720 | JP 13 | 90.77 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 303 | JP 14 | 89.21 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 963 | JP 29 | 87.72 |
| Mitochondrial Function and Pathology | 2021-2025 | 997 | JP 29 | 85.32 |
| Neurological and metabolic disorders | 2021-2025 | 80 | JP 10 | 82.15 |
| Multiple Sclerosis Research Studies | 2021-2025 | 759 | JP 12 | 89.22 |
| Cellular transport and secretion | 2021-2025 | 429 | JP 27 | 81.52 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 657 | JP 30 | 84.67 |
| Restless Legs Syndrome Research | 2021-2025 | 149 | JP 6 | 80.97 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 102 | JP 12 | 78.19 |
| Gastrointestinal motility and disorders | 2021-2025 | 948 | JP 34 | 75.78 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 725 | JP 63 | 69.75 |
| Adenosine and Purinergic Signaling | 2021-2025 | 742 | JP 22 | 66.42 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 847 | JP 32 | 58.99 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 372 | JP 3 | 57.55 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 685 | JP 92 | 50.03 |